As shown by the present results, UPARANT, a compound traditionally supposed to inhibit the interaction between uPAR and FPRs acts here by ameliorating the pathological signs of RP, although in the presence of negligible amount of uPAR and therefore resizing our interpretation on UPARANT mechanism of action. The gene discussed is PLAUR; the disease is retinitis pigmentosa 1.